| 000 | 00837 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513112053.0 | ||
| 264 | 0 | _c19970311 | |
| 008 | 199703s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimoyama, M | |
| 245 | 0 | 0 |
_a[Introduction of anticancer agents to phase I clinical trials]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cJan 1997 |
||
| 300 |
_a246-55 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 24 _gno. 2 _gp. 246-55 |
|
| 999 |
_c9019638 _d9019638 |
||